Skip to main content
HeartFlow10-Q: Clinical milestone

Heartflow starts enrollment in two randomized clinical trials in Q4 2026

Source: Autobound Signal API · 66 signals tracked for HeartFlow · updated

Get HeartFlow's live signals in Claude or ChatGPT, or by API

AskWhat changed at HeartFlow this week? Use Autobound signals for heartflow.com.

What happened

Two randomized clinical trials focused on high-risk asymptomatic subpopulations began enrollment in the fourth quarter of 2026, with a third trial scheduled to start in early 2027. For sellers: expanding clinical trial activity may require contract research organization services and data management tools.

Source

SEC EDGARNov 12, 2026

Quarterly report (Form 10-Q)

HeartFlow 10-Q for Quarter ended Sep 30, 2026

Filing excerpt

For example, we expect enrollment to be underway across three randomized clinical trials focused on high-risk asymptomatic subpopulations to expand the addressable market for our products. … Two of these trials began enrollment in the fourth quarter of 2026, with the third scheduled to start in early 2027.

sec.gov/Archives/edgar/data/1464521/000146452126000173/htfl-20260930x...Read the full source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Clinical milestone

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Sep 30, 2026
Filed
Nov 12, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
1464521
Accession number
0001464521-26-000173
Timeframe
Current quarter
Quarter
Q3
Filing year
2026
Period end date
Sep 30, 2026
Why it matters
Clinical and commercial build-out
Signal category
Strategic

Extraction

Confidence
High
Relevance
70%
Sentiment
Positive
Detected
Nov 17, 2026
signal_type
sec-10q
signal_subtype
clinicalMilestone

Use this data

Get every 10-Q signal for HeartFlow and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at HeartFlow this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/7c9cb057-ca68-4d4a-ba06-4afd4f4a2d52 returns this record as JSON. POST /v1/companies/enrich returns every signal for heartflow.com.

{
  "signal_id": "7c9cb057-ca68-4d4a-ba06-4afd4f4a2d52",
  "signal_type": "sec-10q",
  "signal_subtype": "clinicalMilestone",
  "detected_at": "2026-11-17T07:03:20.005+00:00",
  "company": {
    "name": "HeartFlow",
    "domain": "heartflow.com"
  },
  "data": {
    "detail": "Two randomized clinical trials focused on high-risk asymptomatic subpopulations began enrollment in the fourth quarter of 2026, with a third trial scheduled to start in early 2027. For sellers: expanding clinical trial activity may require contract research organization services and data management tools.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "quarter": "Q3",
    "summary": "Heartflow starts enrollment in two randomized clinical trials in Q4 2026",
    "excerpts": "For example, we expect enrollment to be underway across three randomized clinical trials focused on high-risk asymptomatic subpopulations to expand the addressable market for our products. … Two of these trials began enrollment in the fourth quarter of 2026, with the third scheduled to start in early 2027.",
    "relevance": 0.7,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1464521/000146452126000173/htfl-20260930x10q.htm",
    "filing_date": "2026-11-12",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "period_end_date": "2026-09-30",
    "sales_relevance": "Clinical and commercial build-out",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.